FX Conferences is proud to be the leader in providing convenient distance learning opportunities designed for busy professionals. We partner with leading industry experts to bring you key information and guidance on the latest challenges and hot topics, and our audio conference format makes it easy to participate from the office, at home or on the road. Feel free to browse through our list of coming events, or use our search feature to review past live presentations now available as recordings.

Search By
Industry
Department

Leveraging the Benefits of eMDR (Electronic Medical Device Reporting)

Preview this audio conference


The following is a brief excerpt from this audio conference. It is in mp3 format and will play with most media players. Please Contact Us with any questions you may have.


Click the file name to listen to the excerpt ac20081210_sample.mp3


 


Audio conference highlights


Inefficient medical device reporting presents a clear and present danger: It can damage your company’s reputation and even threaten your ability to operate. After sending some mixed signals in the second half of 2007, FDA eMDR experts have said they’ll mandate eMDR within two years. The only debate now is how quickly it will happen, and what kind of timeline mandate will be imposed.


It’s therefore not surprising to learn the agency is pushing harder for electronic medical device reporting than anyone else. In this audio conference, you'll learn more about the future of eMDR, the options available to you now, and why it makes good business sense to implement an electronic medical device reporting system today.


This audio conference covers:


  • The choices for electronic medical device reporting today
  • How eMDR works
  • Why it will eventually be mandated by the FDA
  • How MDRs are handled today by the FDA
  • Why it's good strategy to get an early start


About the speaker:


Tamar June is the Vice President of Strategic Marketing and Product Manager for eMDR for AssurX, Inc. She has been in the information technology and manufacturing industry for more than 15 years and has published numerous FDA-related and medical device regulatory and technology articles appearing in a variety of publications.


She holds a B.S. degree in marketing from St. Joseph’s University and attended the Katz Graduate School of Business at the University of Pittsburgh.


Who should attend?


  • VP - Quality, Regulatory
  • Product Surveillance
  • Post-market Surveillance
  • Quality Managers
  • Regulatory Managers


*Please note: Each registration covers one line connected to the audio conference. Attendees dialing from separate locations are required to have separate registrations.

Product Details

Tamar June, AssurX
Leveraging the Benefits of eMDR (Electronic Medical Device Reporting)
Title: Vice President of Strategic Marketing
Other Events: Tamar June, AssurX
Duration: 60 minutes
Discount: Buy 2 items, get 25% off your order using coupon code FX25%OFF
Event Type: Previously recorded on 2008-12-10
Item #: ac20081210
10 Dec 2008 
Registration Price:
$249.00

Order Info

Select Order:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 3 reviews)

Showing 3 Reviews:

by P.K.
Regulatory Affairs Supervisor
It was very good, the speed was excellent. In future it will be helpful to have some example how to use the eMDR and the CeSub.
by T.M.
Complaints Manager
This was the first exposure to e-MRD reporting requirements. It was very beneficial and I am sure as we move closure to the mandated timeframe for e-MDR reporting additional gudiance may be available as changes or conditions change.
by E.V.
Regulatory Affairs Specialist
I appreciated very much the availability of the speker to reply to questions. Good training to me.
Rate this item
Similar Events
How to Respond to FDA 483s and Warning Letters
Alan Schwartz, mdi Consultants, Inc.
More about How to Respond to FDA 483s and Warning Letters


Good Reprint Practices: What the FDA Says Now
Robert J. Klepinski, Fredrikson & Byron
More about Good Reprint Practices: What the FDA Says Now


More about The ABCs of FDA: Regulatory, Fraud and Abuse Issues

 

FAQ  |  Medical Translation  |  Search  |  Privacy  |  Terms of Use  |  Contact